$EDIT Requested breakdown 12/15-12/16
Requested Video breadown on $PFE $PFE $EDIT
No need to say anything here, the structure will play out, looking to enter on first 5 min OS then first 15 min OS and first 1 hr OS
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain. I think it has one more leg down. Accumulate in the demand zone.
Hello all, Notice MACD, RSI and 50 day MA trends for EDIT. I am planning to accumulate calls this week and some last week to play the bounce signaled by RSI and MACD into the JPM healthcare conference on the 15th where these biotechs present promising results and play pop. Plus biotech is a risky defensive bet - mutually exclusive of Iran - these biotechs are...
I like the odds in $EDIT, strong chart setup in the 2-day timeframe, earning levels give us a nice estimate of overhead resistance. Chart has been basing for a while, and could be ready to break up from here, after coiling for a long time. I'd reccomend buying into it around here, or maybe buying call options due to earnings risk. Best of luck, Ivan Labrie.
Ticker: EDIT LAST= 26.20 EDITAS MEDICINE INC movement during the last few days showed a Sideways movement, with a recent low price seen on Mon 24.Dec.2018 at 17.80 The Short-Term view is expected to continue to be UP as long as the price is above 25.75, and it's recommended to ' BE LONG ' for a targeted price of around 29.40 Taking in consideration the...
Sun 02/Dec/2018 Ticker: EDIT LAST= 31.16 EDITAS MEDICINE INC movement during the last few days showed a Bullish move, with a recent high price seen on Fri 30.Nov.2018 at 31.21. During the next few days the price is expected to go up for 31.21 and then to 32.40. The Short-Term view is expected to continue to be UP as long as the price is above 29.05. But...
A tight stop could be set here but I went with a bit looser one that would confirm a break down from trendline. Could be held long term or short. Good risk:reward. The topic of genesiology/eugenics may be ignored and considered morally reprehensible in modern society, but appears to be inevitable. I will ignore moral argument for this discussion. The film...
NTLA has been flying through resistance levels from oversold conditions and looks like it's testing 17.28 resistance to establish it as support. If it closes above, likely going higher - if it rejects off of 17.28 then likely retest of high 15s before re-testing 17s. Apart from ongoing patent battles, this company was hit by a scientific paper that made unfounded...
Nice support level at $20 Filled Gap up and Gap down. If decent trading volume, long term investors or proponents to CAS-9 research will buy in at these support levels. CRISPR got upgraded. EDITAS holds patents that relate to the use of CRISPR-Cas9 in the cells of humans and other eukaryotes, while the UC Berkeley, Crispr, patents cover use of the gene-editing...
EDIT had a lovely flag setup. It continued further up and started to consolidating within a downward channel. Now it seems broken out the channel formation. We think it has good upside potential from here. * Trade Criteria * Date first found- March 13 Pattern/Why- Flag formation; Downward channel breakout Entry Target Criteria- Break of $25.21 Exit Target...
EDIT looks like an awesome flag formation. We sent this out during Fridays Live trading session. It looks like a great flag from $24 and upward. * Trade Criteria * Date First Found- February 17, 2017 (In Live trading session) Pattern/Why- Strong flag potential Entry Target Criteria- Break of $24 or above Exit Target Criteria- $31.57 Stop Loss Criteria-...
EDIT formed a fallen angel formation & showing strong upward momentum. It had a good run after we suggested in trading room last week. Now we are looking for a second entry if it pull back to 15.83 or break 16.44 You can check our detailed analysis on EDIT in the trading room/ Executive summary link here- www.youtube.com Time Span: 6:00" Trade Status: Pending